In light of the above findings, the present study tested the hypothesis that DPPIV inhibition attenuates cardiac dysfunction in rats with a 5/6 renal ablation, an experimental model of CKD that is not associated with hyperglycemia. Here, DPP4 is linked to chronic kidney disease.